The National Institute of Mental Health (NIMH) awarded a 5-year, $194,157 Project Grant (CFDA 93.242 Mental Health Research Grants) to the Icahn School of Medicine at Mount Sinai to develop and pilot a novel intervention to treat post-COVID-19 cognitive impairment and depression. The project aims to integrate two evidence-based therapies - cognitive rehabilitation based on goal management training, and cognitive behavioral therapy - and adapt the intervention for ethnically diverse patients. Qualitative research with patient focus groups will inform the intervention development, which will then be evaluated for feasibility and preliminary efficacy in a pilot randomized controlled trial. This research supports the career development of the principal investigator, Dr. Jacqueline Becker, who is building expertise in areas such as qualitative methods, psychosocial intervention development, and clinical trial design.
Generated 3/25/25, 3:41 AM